Atlas Trials

Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Clinical trial NCT02512302 · COMPLETED

Trial details

NCT number
NCT02512302
Sponsor
Sunovion Respiratory Development Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COPD
Start date
2015-10-01
Primary completion
2016-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.